Results
2
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
2 companies
RaQualia Pharma
Market Cap: JP¥15.2b
Engages in the research and development of pharmaceutical compounds worldwide.
4579
JP¥620.00
7D
-4.3%
1Y
1.3%
Nxera Pharma
Market Cap: JP¥80.9b
Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.
4565
JP¥900.00
7D
-5.2%
1Y
-40.8%